MAHBOOB ALAM to Treatment Outcome
This is a "connection" page, showing publications MAHBOOB ALAM has written about Treatment Outcome.
Connection Strength
0.838
-
Drug-Coated Balloon Failure Following Femoro-Popliteal Intervention: Where to Draw the Line? J Am Coll Cardiol. 2022 09 27; 80(13):1251-1253.
Score: 0.049
-
Meta-Analysis Comparing Distal Radial Versus Traditional Radial Percutaneous Coronary Intervention or Angiography. Am J Cardiol. 2022 05 01; 170:31-39.
Score: 0.047
-
Association of Body Mass Index With Outcomes in Patients Undergoing Percutaneous Left Atrial Appendage Closure With the Watchman Device. Curr Probl Cardiol. 2022 12; 47(12):101009.
Score: 0.046
-
Comparative analysis of revascularization with percutaneous coronary intervention versus coronary artery bypass surgery for patients with end-stage renal disease: a nationwide inpatient sample database. Expert Rev Cardiovasc Ther. 2021 Aug; 19(8):763-768.
Score: 0.046
-
Predictors of In-Hospital Mortality in Patients With End-Stage Renal Disease Undergoing Transcatheter Aortic Valve Replacement: A Nationwide Inpatient Sample Database Analysis. Cardiovasc Revasc Med. 2022 01; 34:63-68.
Score: 0.044
-
Percutaneous coronary intervention in patients with cardiac allograft vasculopathy: a Nationwide Inpatient Sample (NIS) database analysis. Expert Rev Cardiovasc Ther. 2021 Mar; 19(3):269-276.
Score: 0.044
-
Prescription Patterns of Clopidogrel, Prasugrel, and Ticagrelor After Percutaneous Coronary Intervention With Stent Implantation (from the NCDR PINNACLE Registry). Am J Cardiol. 2019 12 15; 124(12):1807-1812.
Score: 0.040
-
Upsloping ST depression: Is it acute ischemia? Ann Noninvasive Electrocardiol. 2019 05; 24(3):e12607.
Score: 0.038
-
Meta-Analysis of Comparison of 5-Year Outcomes of Percutaneous Coronary Intervention Versus Coronary Artery Bypass Grafting in Patients With Unprotected Left Main Coronary Artery in the Era of Drug-eluting Stents. Am J Cardiol. 2017 Nov 01; 120(9):1514-1520.
Score: 0.034
-
Comparison by meta-analysis of percutaneous coronary intervention versus coronary artery bypass grafting in patients with a mean age of =70 years. Am J Cardiol. 2013 Sep 01; 112(5):615-22.
Score: 0.026
-
Percutaneous coronary intervention vs. coronary artery bypass graft surgery for unprotected left main coronary artery disease in the drug-eluting stents era--an aggregate data meta-analysis of 11,148 patients. Circ J. 2013; 77(2):372-82.
Score: 0.025
-
Clinical outcomes of percutaneous interventions in saphenous vein grafts using drug-eluting stents compared to bare-metal stents: a comprehensive meta-analysisof all randomized clinical trials. Clin Cardiol. 2012 May; 35(5):291-6.
Score: 0.024
-
Long-term clinical outcomes after percutaneous coronary intervention for unprotected left main coronary artery in heart transplant patients with cardiac allograft vasculopathy. Int J Cardiol. 2012 Apr 05; 156(1):101-4.
Score: 0.023
-
Isolated coronary artery bypass grafting in obese individuals: a propensity matched analysis of outcomes. Circ J. 2011; 75(6):1378-85.
Score: 0.022
-
Cardiovascular Outcomes of Transcatheter Aortic Valve Implantation in Patients With Chronic Kidney Disease in Octogenarian Population. Am J Cardiol. 2024 Jan 15; 211:163-171.
Score: 0.013
-
Cardiovascular Outcomes of Transulnar Versus Transradial Percutaneous Coronary Angiography and Intervention: A Regression Matched Meta-Analysis. Am J Cardiol. 2023 08 15; 201:92-100.
Score: 0.013
-
Revascularization Options for Left Main Disease: What Clinicians Need to Know. Curr Atheroscler Rep. 2023 06; 25(6):267-273.
Score: 0.013
-
Clinical Outcomes of Transcatheter Aortic Valve Replacement (TAVR) Vs. Surgical Aortic Valve Replacement (SAVR) in Patients With Durable Left Ventricular Assist Device (LVAD). Curr Probl Cardiol. 2022 Oct; 47(10):101313.
Score: 0.012
-
Routine Invasive Strategy in Elderly Patients with Non-ST Elevation Acute Coronary Syndrome: An Updated Systematic Review and Meta-analysis of Randomized Trials. Curr Probl Cardiol. 2022 Oct; 47(10):101304.
Score: 0.012
-
Outcomes of MitraClip and Surgical Mitral Valve Repair in Patients With Left Ventricular Assist Device. Am J Cardiol. 2022 06 15; 173:143-145.
Score: 0.012
-
Do We Really Need Aspirin Loading for STEMI? Cardiovasc Drugs Ther. 2022 12; 36(6):1221-1238.
Score: 0.012
-
Cerebral Embolic Protection during Transcatheter Aortic Valve Implantation: Updated Systematic Review and Meta-Analysis. Curr Probl Cardiol. 2023 Jun; 48(6):101127.
Score: 0.012
-
Outcomes of Transcatheter Aortic Valve Implantation in Patients With Chronic and End-Stage Kidney Disease. Am J Cardiol. 2022 02 01; 164:100-102.
Score: 0.012
-
Trends and Outcomes of Ischemic Stroke after Transcatheter Aortic Valve Implantation, A US National Propensity Matched Analysis. Curr Probl Cardiol. 2022 Oct; 47(10):100961.
Score: 0.011
-
Meta-analysis comparing valve-in-valve TAVR and redo-SAVR in patients with degenerated bioprosthetic aortic valve. Catheter Cardiovasc Interv. 2021 11 01; 98(5):940-947.
Score: 0.011
-
Long-Term Outcomes Comparing Medical Therapy versus Revascularization for Spontaneous Coronary Artery Dissection. Am J Med. 2021 07; 134(7):e403-e408.
Score: 0.011
-
Efficacy of Long-Term Oral Beta-Blocker Therapy in Patients Who Underwent Percutaneous Coronary Intervention for ST-Segment Elevation Myocardial Infarction With Preserved Left Ventricular Ejection Fraction: A Systematic Review and Meta-analysis. J Cardiovasc Pharmacol. 2021 01 01; 77(1):87-93.
Score: 0.011
-
Meta-Analysis Comparing Culprit-Only Versus Complete Multivessel Percutaneous Coronary Intervention in Patients With ST-Elevation Myocardial Infarction. Am J Cardiol. 2021 01 15; 139:34-39.
Score: 0.011
-
Statin Prescription Rates, Adherence, and Associated Clinical Outcomes Among Women with PAD and ICVD. Cardiovasc Drugs Ther. 2020 12; 34(6):745-754.
Score: 0.011
-
Inferior ST-Elevation Myocardial Infarction Presenting When Urgent Primary Percutaneous Coronary Intervention Is Unavailable: Should We Adhere to Current Guidelines? Cardiovasc Drugs Ther. 2020 12; 34(6):865-870.
Score: 0.011
-
A Modern History RAAS Inhibition and Beta Blockade for Heart Failure to Underscore the Non-equivalency of ACEIs and ARBs. Cardiovasc Drugs Ther. 2020 04; 34(2):215-221.
Score: 0.010
-
Pathophysiology, Diagnosis, and Management of the No-Reflow Phenomenon. Cardiovasc Drugs Ther. 2019 10; 33(5):589-597.
Score: 0.010
-
Outcomes following percutaneous coronary intervention in patients with cancer. Int J Cardiol. 2020 02 01; 300:106-112.
Score: 0.010
-
Association of Body Mass Index With Risk Factor Optimization and Guideline-Directed Medical Therapy in US Veterans With Cardiovascular Disease. Circ Cardiovasc Qual Outcomes. 2019 01; 12(1):e004817.
Score: 0.010
-
Do We Need Potent Intravenous Antiplatelet Inhibition at the Time of Reperfusion During ST-Segment Elevation Myocardial Infarction? J Cardiovasc Pharmacol Ther. 2019 05; 24(3):215-224.
Score: 0.009
-
SGLT2 Inhibitors and Cardiovascular Outcomes: Current Perspectives and Future Potentials. Curr Diab Rep. 2018 07 11; 18(9):63.
Score: 0.009
-
Ticagrelor Use in Acute Myocardial Infarction: Insights From the National Cardiovascular Data Registry. J Am Heart Assoc. 2018 06 09; 7(12).
Score: 0.009
-
GLP-1 Receptor Agonists and Cardiovascular Disease: a Meta-Analysis of Recent Cardiac Outcome Trials. Cardiovasc Drugs Ther. 2018 02; 32(1):65-72.
Score: 0.009
-
Trends and Outcomes of Off-label Use of Transcatheter Aortic Valve Replacement: Insights From the NCDR STS/ACC TVT Registry. JAMA Cardiol. 2017 08 01; 2(8):846-854.
Score: 0.009
-
Efficacy of Angiotensin-Converting Enzyme Inhibitors and Angiotensin-Receptor Blockers in Coronary Artery Disease without Heart Failure in the Modern Statin Era: a Meta-Analysis of Randomized-Controlled Trials. Cardiovasc Drugs Ther. 2016 Apr; 30(2):189-98.
Score: 0.008
-
A case of biventricular failure after pericardial window for large pericardial effusion. Heart Surg Forum. 2015 Feb 27; 18(1):E36-7.
Score: 0.007
-
Coronary artery disease performance measures and statin use in patients with recent percutaneous coronary intervention or recent coronary artery bypass grafting (from the NCDR PINNACLE registry). Am J Cardiol. 2015 Apr 15; 115(8):1013-8.
Score: 0.007
-
Frequency and practice-level variation in inappropriate and nonrecommended prasugrel prescribing: insights from the NCDR PINNACLE registry. J Am Coll Cardiol. 2014 Jul 01; 63(25 Pt A):2876-7.
Score: 0.007
-
Stellate ganglion block: a therapeutic alternative for patients with medically refractory inappropriate sinus tachycardia? J Electrocardiol. 2013 Nov-Dec; 46(6):693-6.
Score: 0.006
-
Coronary artery bypass graft surgery remains the standard of care for patients with diabetes. Semin Thorac Cardiovasc Surg. 2013; 25(2):97-9.
Score: 0.006
-
Association between statins and infections after coronary artery bypass grafting. Int J Cardiol. 2013 Sep 20; 168(1):117-20.
Score: 0.006
-
Outcomes of preoperative angiotensin-converting enzyme inhibitor therapy in patients undergoing isolated coronary artery bypass grafting. Am J Cardiol. 2012 Oct 01; 110(7):919-23.
Score: 0.006
-
An analysis of surgical shunts for the management of portal hypertension at Aga Khan University Hospital. J Ayub Med Coll Abbottabad. 2004 Oct-Dec; 16(4):70-4.
Score: 0.004